Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
Saved in:
| Title: | Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients. |
|---|---|
| Authors: | Webb MJ; Department of Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Neth BJ; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Webb LM; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Van Gompel JJ; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Link MJ; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Neff BA; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Carlson ML; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Driscoll CL; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Dornhoffer J; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA., Ruff MW; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Anderson KA; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Kizilbash SH; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Campian JL; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Uhm JH; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Lane JI; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Benson JC; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Blezek DJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Mehta PM; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Bathla G; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Sener UT; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2023 Sep 22; Vol. 5 (1), pp. vdad123. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
